Showing 61 - 80 results of 1,931 for search '"cholangiocarcinoma"', query time: 0.09s Refine Results
  1. 61

    Novel Targeted Therapies for Advanced Cholangiocarcinoma by Alessandro Rizzo, Giovanni Brandi

    Published 2021-02-01
    “…Cholangiocarcinoma (CCA) includes a group of rare and aggressive hepatobiliary malignancies, including extrahepatic cholangiocarcinoma (eCCA) and intrahepatic cholangiocarcinoma (iCCA), with the former further subdivided into distal (dCCA) and perihilar cholangiocarcinoma (pCCA) [...]…”
    Get full text
    Article
  2. 62
  3. 63

    Cholangiocarcinoma: Molecular Abnormalities and Cells of Origin by Ugo Testa MD, Elvira Pelosi PhD, Germana Castelli PhD

    Published 2023-03-01
    “…Cholangiocarcinomas (CCAs) are a group of heterogeneous epithelial malignancies that can originate at the level of any location of the biliary tree. …”
    Get full text
    Article
  4. 64
  5. 65
  6. 66

    Therapeutic Potential of Autophagy Modulation in Cholangiocarcinoma by Hector Perez-Montoyo

    Published 2020-03-01
    Subjects: “…cholangiocarcinoma…”
    Get full text
    Article
  7. 67
  8. 68
  9. 69

    The focus clinical research in intrahepatic cholangiocarcinoma by Yinghui Song, Mengting Cai, Yuhang Li, Sulai Liu

    Published 2022-07-01
    Subjects: “…Intrahepatic cholangiocarcinoma…”
    Get full text
    Article
  10. 70

    Fluke-Related Cholangiocarcinoma: Challenges and Opportunities by J. Luis Espinoza

    Published 2023-12-01
    “…Cholangiocarcinoma encompasses a heterogeneous group of highly aggressive malignancies, arising from the biliary tract, that are often associated with poor survival rates [...]…”
    Get full text
    Article
  11. 71
  12. 72
  13. 73
  14. 74
  15. 75

    Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma by Massimiliano Cadamuro, Simone Brivio, Carlo Spirli, Ruth E. Joplin, Mario Strazzabosco, Luca Fabris

    Published 2017-01-01
    “…Resistance to conventional chemotherapeutic agents, a typical feature of cholangiocarcinoma, prevents the efficacy of the therapeutic arsenal usually used to combat malignancy in humans. …”
    Get full text
    Article
  16. 76
  17. 77
  18. 78
  19. 79

    Bile metabolites as diagnostic biomarkers for perihilar cholangiocarcinoma by DengYong Zhang, GuanRu Zhao, Wanliang Sun, Dongdong Wang, Shuo Zhou, Zhong Liu, Zheng Lu

    Published 2023-02-01
    “…Abstract It is difficult to directly obtain pathological diagnosis of perihilar cholangiocarcinoma (pCCA). Analysis of bile in the pCCA microenvironment, based on metabolomics and statistical methods, can help in clinical diagnosis. …”
    Get full text
    Article
  20. 80